-
-
-
-
-
-
-
BioXcel Therapeutics (BTAI) Misses Q1 EPS by 129c
-
-
-
-
-
-
-
BioXcel Therapeutics (BTAI) PT Lowered to $7 at H.C. Wainwright
-
-
-
-
-
-
-
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
-
-
-
-
-
-
-
BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14, 2023
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioXcel, Seagate, Baxter, and Danaher and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights
-
-
-
-
-
-
-
BioXcel Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
-
1,197,440 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

